Gland Pharma

Gland Pharma gets EIR from US FDA for Pashamylaram facility after successful GMP inspection

Gland Pharma receives EIR from US FDA for Dundigal facility after successful GMP inspection

Gland Pharma shares rise nearly 2% following NSE’s inclusion in F&O contracts

Gland Pharma subsidiary Cenexi receives 10 observations from ANSM inspection

Gland Pharma stock jump 3% on USFDA approval for Phytonadione Injectable Emulsion

Gland Pharma gets USFDA nod for Latanoprost Ophthalmic Solution

Gland Pharma stock jumps 10% this week after Q2 results

Gland Pharma shares jump 6% on Q2 FY25 results

Stocks Update: Phoenix Mills drops 4.77%, Gland Pharma down 3.73%, and United Spirits loses 3.61% in today’s session

Goldman Sachs downgrades Gland Pharma to ‘Sell’, expects 19% downside

Gland Pharma shares fall as Q1 net profit declines 26% to ₹143.8 crore

Gland Pharma Q1 Results: Net profit drops by 26%, revenue increases by 16%

Gland Pharma shares fall 5% after two entities set to sell 4.4% stake

Gland Pharma shares surge over 6% after US FDA approval for breast cancer drug

Stocks to watch: Adani Ports, Wipro, Tata Power, Vedanta and more

Elantas Beck India will be one of the companies to watch today as it reports its December quarter results.